Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 58.80
+0.50 (0.86%)
At close: Apr 29, 2026
Navana Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Net Income | 609.04 | 487.81 | 404.63 | 356.94 | 274 | 202.29 | Upgrade
|
| Depreciation & Amortization | 349.5 | 320.65 | 214.96 | 210.41 | 165.84 | 87.27 | Upgrade
|
| Other Amortization | 0.33 | 0.22 | 0.22 | - | 0.22 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | 7.65 | 7.65 | -1.18 | - | -0.47 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.44 | 10.46 | -123.14 | 46.8 | -82.9 | - | Upgrade
|
| Other Operating Activities | 537.54 | 175.8 | 341.5 | 134.99 | 147.08 | 75.47 | Upgrade
|
| Change in Accounts Receivable | -142.11 | -175.36 | -218.89 | -253.42 | -84.93 | -74.38 | Upgrade
|
| Change in Inventory | 55.54 | 88.47 | -620.6 | -344.07 | -200.76 | -95.7 | Upgrade
|
| Change in Accounts Payable | 550.93 | 417.03 | 332.93 | 152.22 | 79.44 | 8.78 | Upgrade
|
| Change in Other Net Operating Assets | 384.63 | 482.28 | 376.88 | -110.13 | -98.16 | -82.11 | Upgrade
|
| Operating Cash Flow | 2,347 | 1,815 | 707.3 | 193.74 | 199.36 | 121.75 | Upgrade
|
| Operating Cash Flow Growth | 146.12% | 156.61% | 265.07% | -2.82% | 63.74% | -39.58% | Upgrade
|
| Capital Expenditures | -276.03 | -370.89 | -1,332 | -1,598 | -1,359 | -520.75 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.46 | - | 1.48 | - | - | - | Upgrade
|
| Investment in Securities | -50.66 | -10.46 | 13.48 | -2.33 | -171.48 | 53.65 | Upgrade
|
| Other Investing Activities | -0.36 | 0.32 | 1.14 | 2.79 | 3.26 | -1.17 | Upgrade
|
| Investing Cash Flow | -325.59 | -381.03 | -1,316 | -1,598 | -1,527 | -468.28 | Upgrade
|
| Short-Term Debt Issued | - | - | 942.14 | 1,384 | 1,551 | 360.66 | Upgrade
|
| Long-Term Debt Issued | - | - | 121.97 | - | 17.74 | 93.09 | Upgrade
|
| Total Debt Issued | -31.89 | - | 1,064 | 1,384 | 1,569 | 453.75 | Upgrade
|
| Short-Term Debt Repaid | - | -724.88 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -51.82 | -16.26 | -66.46 | -45.83 | -72.02 | Upgrade
|
| Total Debt Repaid | -997.05 | -776.7 | -16.26 | -66.46 | -45.83 | -72.02 | Upgrade
|
| Net Debt Issued (Repaid) | -1,029 | -776.7 | 1,048 | 1,318 | 1,523 | 381.73 | Upgrade
|
| Issuance of Common Stock | - | - | - | 750 | - | - | Upgrade
|
| Common Dividends Paid | -43.8 | -41.56 | -136.88 | -113.15 | - | - | Upgrade
|
| Other Financing Activities | -1,018 | -698.96 | -475.12 | -175.98 | -154.73 | -64.15 | Upgrade
|
| Financing Cash Flow | -2,091 | -1,517 | 435.84 | 1,778 | 1,368 | 317.59 | Upgrade
|
| Foreign Exchange Rate Adjustments | -3.99 | - | - | - | 0.05 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | 0.05 | -0 | - | Upgrade
|
| Net Cash Flow | -73.96 | -83.24 | -173.16 | 374.5 | 40.65 | -28.94 | Upgrade
|
| Free Cash Flow | 2,071 | 1,444 | -625.1 | -1,404 | -1,160 | -399 | Upgrade
|
| Free Cash Flow Margin | 20.55% | 16.33% | -9.06% | -24.61% | -24.37% | -11.06% | Upgrade
|
| Free Cash Flow Per Share | 19.19 | 13.44 | -5.82 | -14.13 | -14.45 | -4.97 | Upgrade
|
| Cash Interest Paid | 1,018 | 698.96 | 475.12 | 157.9 | 142.83 | 64.15 | Upgrade
|
| Cash Income Tax Paid | 150.73 | 148.76 | 131.47 | 101 | 110.27 | 88.79 | Upgrade
|
| Levered Free Cash Flow | 1,337 | 1,039 | -1,180 | -2,393 | -1,836 | -461.76 | Upgrade
|
| Unlevered Free Cash Flow | 1,736 | 1,493 | -889.89 | -2,246 | -1,711 | -414.77 | Upgrade
|
| Change in Working Capital | 848.99 | 812.42 | -129.68 | -555.4 | -304.41 | -243.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.